Metabolite

KNApSAcK Entry

id C00003070
Name Amarogentin
CAS RN 21018-84-8
Standard InChI InChI=1S/C29H30O13/c1-2-16-17-6-7-38-26(36)19(17)12-39-28(16)42-29-25(24(35)23(34)21(11-30)40-29)41-27(37)22-18(9-15(32)10-20(22)33)13-4-3-5-14(31)8-13/h2-5,8-10,12,16-17,21,23-25,28-35H,1,6-7,11H2/t16-,17+,21?,23-,24+,25?,28+,29+/m1/s1
Standard InChI (Main Layer) InChI=1S/C29H30O13/c1-2-16-17-6-7-38-26(36)19(17)12-39-28(16)42-29-25(24(35)23(34)21(11-30)40-29)41-27(37)22-18(9-15(32)10-20(22)33)13-4-3-5-14(31)8-13/h2-5,8-10,12,16-17,21,23-25,28-35H,1,6-7,11H2

Cluster

Phytochemical cluster
KCF-S cluster No. 2478

Link

ChEMBL

By standard InChI
By standard InChI Main Layer

KEGG

By LinkDB C09767

CTD

By CAS RN C102609

Human Protein / Gene in interaction

CTD interaction (1)

compound gene gene name gene description interaction interaction type form reference
pmid
C102609 259296 TAS2R50
T2R50
T2R51
TAS2R51
taste receptor, type 2, member 50 amarogentin binds to and results in increased activity of TAS2R50 protein affects binding
/ increases activity
protein 19817411

Related Disease

Diseases related to CTD interactions

3 disease from interactions of metabolites

MeSH disease OMIM compound disease name evidence type reference
pmid
D007898 C102609 Leishmaniasis, Visceral therapeutic
10590280
D010212 C102609 Papilloma therapeutic
15173996
16517061
D012878 C102609 Skin Neoplasms therapeutic
15173996
16517061